RecruitingNot applicableNCT06572475
USPIO Enhanced MR Imaging in CNS Tumours (UMIC)
Studying Vestibular schwannoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Northern Care Alliance NHS Foundation Trust
- Principal Investigator
- David Coope, PhD FRCS(SN)Northern Care Alliance NHS Foundation Trust
- Intervention
- USPIO enhanced MRI(diagnostic_test)
- Enrollment
- 17 enrolled
- Eligibility
- 16-100 years · All sexes
- Timeline
- 2024 – 2026
Study locations (1)
- Salford Royal Hospital Northern Care Alliance NHS Foundation Trust, Salford, Greater Manchester, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06572475 on ClinicalTrials.govOther trials for Vestibular schwannoma
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07503613Long Term Follow-up Study of AAVAnc80-antiVEGF Gene TherapyAkouos, Inc.
- RECRUITINGNANCT07364955Vestibular Rehabilitation Protocol in Unilateral Vestibular SchwannomaAlbert Torrents Torrero
- ACTIVE NOT RECRUITINGNANCT07130851Mapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular SchwannomaMarketa Bonaventurova
- RECRUITINGNANCT06660082Early Rehabilitation Using Head Impulse Test for Acute Vestibular DeficitHospices Civils de Lyon
- RECRUITINGPHASE1, PHASE2NCT06517888Anti-VEGF Gene Therapy Trial for Vestibular SchwannomaAkouos, Inc.
- RECRUITINGNANCT06112509Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgeryCentre Hospitalier Universitaire de Besancon
- RECRUITINGNANCT05702749Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular SchwannomasMedical College of Wisconsin
- RECRUITINGNCT05641441Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular SchwannomaUniversity Hospital, Geneva